The 10-second takeaway
For the quarter ended Dec. 31 (Q3), McKesson beat expectations on revenues and beat expectations on earnings per share.
Compared to the prior-year quarter, revenue grew, and GAAP earnings per share grew significantly.
Gross margins dropped, operating margins shrank, net margins improved.
McKesson booked revenue of $30.84 billion. The 16 analysts polled by S&P Capital IQ anticipated a top line of $30.19 billion. Sales were 9.2% higher than the prior-year quarter's $28.20 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions.
Non-GAAP EPS came in at $1.40. The 16 earnings estimates compiled by S&P Capital IQ averaged $1.38 per share on the same basis. GAAP EPS of $1.20 for Q3 were 100% higher than the prior-year quarter's $0.60 per share.
Source: S&P Capital IQ. Quarterly periods. Figures may be non-GAAP to maintain comparability with estimates.
For the quarter, gross margin was 5.1%, 10 basis points worse than the prior-year quarter. Operating margin was 1.7%, 10 basis points worse than the prior-year quarter. Net margin was 1.0%, 50 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $30.04 billion. On the bottom line, the average EPS estimate is $2.05.
Next year's average estimate for revenue is $120.46 billion. The average EPS estimate is $6.28.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on McKesson is outperform, with an average price target of $95.83.
If you're interested in health care stocks like McKesson, you might want to expand your horizons to find maximum returns. Follow the money and meet a prime candidate for major returns in our new report, "Discover the Next Rule-Breaking Multibagger." Click here for instant access to this free report.
- Add McKesson to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Motley Fool newsletter services have recommended buying shares of McKesson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.